1. Recognition of amphetamine addicts;Ashcroft, G.W.; Eccleston, D.; Waddell, J.L.;British Medical Journal,1965
2. Der L-Dioxyphenylalanin (=L-dopa)-Effekt beim ParkinsonSyndrom des Menschen: zur Pathogenese und Behandlung der;Birkmayer, W.; Hornykiewicz, 0,1962
3. Antiparkinsonian drugs. Pharmacological and therapeutic aspects;Calne, D.B.; Reid, J.L.;Drugs,1972
4. Amphetamine and brain catecholamines;Carlsson, A.,1970
5. The use of benzedrine sulfate in postencephalitic parkinsonism;Davis, P.L.; Stewart, W.B.;Journal of the American Medical Association,1938